Cargando…
PARP inhibition causes premature loss of cohesion in cancer cells
Poly(ADP-ribose) polymerases (PARPs) regulate various aspects of cellular function including mitotic progression. Although PARP inhibitors have been undergoing various clinical trials and the PARP1/2 inhibitor olaparib was approved as monotherapy for BRCA-mutated ovarian cancer, their mode of action...
Autores principales: | Kukolj, Eva, Kaufmann, Tanja, Dick, Amalie E., Zeillinger, Robert, Gerlich, Daniel W., Slade, Dea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732777/ https://www.ncbi.nlm.nih.gov/pubmed/29262611 http://dx.doi.org/10.18632/oncotarget.21879 |
Ejemplares similares
-
PARP and PARG inhibitors in cancer treatment
por: Slade, Dea
Publicado: (2020) -
SIRT2 regulates nuclear envelope reassembly through ANKLE2 deacetylation
por: Kaufmann, Tanja, et al.
Publicado: (2016) -
Age-Related Loss of Cohesion: Causes and Effects
por: Cheng, Jin-Mei, et al.
Publicado: (2017) -
Loss of ATRX leads to chromosome cohesion and congression defects
por: Ritchie, Kieran, et al.
Publicado: (2008) -
Persistent telomere cohesion protects aged cells from premature senescence
por: Azarm, Kameron, et al.
Publicado: (2020)